510(k) K201269
K201269 is an FDA 510(k) premarket notification submitted by Mesa Biotech, Inc. for the device "Accula Strep A Test". The FDA issued a decision of Substantially Equivalent on Nov 9, 2020. The device falls under product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System), a Class II device regulated under 21 CFR 866.2680. Mesa Biotech, Inc. has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 9, 2020
- Date Received
- May 12, 2020
- Clearance Type
- Dual Track
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Device Class
- Class II
- Regulation Number
- 866.2680
- Review Panel
- MI
- Submission Type
- 510(k)
An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.
Need the full FDA record for Mesa Biotech, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.